Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
SAFETY OF ERYTHROMYCIN VERSUS CLARITHROMYCIN IN ADULTS AND ADOLESCENTS WITH PNEUMONIA: META-ANALYSIS
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: ELJAALY, Khalid (King Abdulaziz University, Pharmacy Practice, Saudi Arabia)
- Co-author(s): Khalid Eljaaly: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia;Pharmacy Practice & Science, University of Arizona, Tucson, United States
Ahmed Botaish: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
Fawaz Bahobail: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
Mohamed Almehmadi: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
Ziyad Assabban: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
Abrar Thabit: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia - Abstract:
Background
It is debatable whether erythromycin is associated with more adverse drug reactions (ADRs) compared to clarithromycin, and both are recommended in clinical practice guidelinesMethods
Two investigators independently searched PubMed, EMBASE and Cochrane Library databases through Feb 07, 2019. Randomized-controlled trials (RCTs) comparing.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 October 2019